Header Logo

Connection

Naoko Takebe to Ribonucleotide Reductases

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Ribonucleotide Reductases.
Naoko Takebe
Connection Strength
0.072
Ribonucleotide Reductases
  1. Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies. Leuk Res. 2007 Sep; 31(9):1165-73.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.